Table 7. 5-aza increases DNMT1 and DNMT3B, with a similar trend in the presence of TGF-β1.
DNMT1 (n=10) | DNMT3A (n=10) | DNMT3B (n=9) | ||||
---|---|---|---|---|---|---|
Median (min, max) | P value | Median (min, max) | P value | Median (min, max) | P value | |
SF | 1.61 (0.97, 3.99) | 0.005 | 1.30 (0.23, 4.40) | 0.310 | 1.53 (1.07, 3.84) | 0.002 |
TGF-β1 | 1.41 (0.85, 3.07) | 0.015 | 0.65 (0.52, 2.33) | 0.062 | 1.54 (0.71, 4.25) | 0.067 |
Human gingival fibroblasts were exposed to 5-aza or left untreated for 72 hours, before cells were stimulated with recombinant human TGF-β1 or left in serum-free medium alone. After 24 hours, the gene expression analysis was performed. P values reflect the ratio of gene expression in response to 5-aza compared to unstimulated cells. Statistical analyses were based on fold-change values with the paired t-test.
5-aza: 5-aza-2'-deoxycytidine, DNMT: DNA methyltransferase, TGF-β1: transforming growth factor-β1, min: minimum, max: maximum, SF: serum-free.